These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


100 related items for PubMed ID: 9604815

  • 1. Mechanisms of oxalate cellular transport in idiopathic calcium nephrolithiasis.
    Baggio B, Gambaro G.
    J Nephrol; 1998; 11 Suppl 1():63-5. PubMed ID: 9604815
    [No Abstract] [Full Text] [Related]

  • 2. Specific modulatory effect of arachidonic acid on human red blood cell oxalate transport: clinical implications in calcium oxalate nephrolithiasis.
    Baggio B, Priante G, Brunati AM, Clari G, Bordin L.
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S381-4. PubMed ID: 10541268
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Raised transmembrane oxalate flux in red blood cells in idiopathic calcium oxalate nephrolithiasis.
    Baggio B, Gambaro G, Marchini F, Cicerello E, Borsatti A.
    Lancet; 1984 Jul 07; 2(8393):12-3. PubMed ID: 6145933
    [Abstract] [Full Text] [Related]

  • 5. Idiopathic calcium oxalate nephrolithiasis: a cellular disease.
    Gambaro G, Baggio B.
    Scanning Microsc; 1992 Mar 07; 6(1):247-54. PubMed ID: 1626244
    [Abstract] [Full Text] [Related]

  • 6. [Oxalate as a promoter in calcium oxalate nephrolithiasis].
    Yamakawa K, Katou T, Arima K, Yanagawa M, Kawamura J.
    Hinyokika Kiyo; 1991 Oct 07; 37(10):1111-4. PubMed ID: 1755400
    [Abstract] [Full Text] [Related]

  • 7. Evidence of a link between erythrocyte band 3 phosphorylation and anion transport in patients with 'idiopathic' calcium oxalate nephrolithiasis.
    Baggio B, Bordin L, Gambaro G, Piccoli A, Marzaro G, Clari G.
    Miner Electrolyte Metab; 1993 Oct 07; 19(1):17-20. PubMed ID: 8393959
    [Abstract] [Full Text] [Related]

  • 8. Oxalate in renal stone disease: the terminal metabolite that just won't go away.
    Marengo SR, Romani AM.
    Nat Clin Pract Nephrol; 2008 Jul 07; 4(7):368-77. PubMed ID: 18523430
    [Abstract] [Full Text] [Related]

  • 9. Oxalate transport and calcium oxalate renal stone disease.
    Verkoelen CF, Romijn JC.
    Urol Res; 1996 Jul 07; 24(4):183-91. PubMed ID: 8873376
    [Abstract] [Full Text] [Related]

  • 10. [Nephrolithiasis and the gastrointestinal tract].
    Caspary WF.
    Z Gastroenterol Verh; 1979 Jul 07; 16():122-36. PubMed ID: 95364
    [No Abstract] [Full Text] [Related]

  • 11. Correction of erythrocyte abnormalities in idiopathic calcium-oxalate nephrolithiasis and reduction of urinary oxalate by oral glycosaminoglycans.
    Baggio B, Gambaro G, Marchini F, Marzaro G, Williams HE, Borsatti A.
    Lancet; 1991 Aug 17; 338(8764):403-5. PubMed ID: 1678082
    [Abstract] [Full Text] [Related]

  • 12. Calcium oxalate nephrolithiasis: defective oxalate transport.
    Borsatti A.
    Kidney Int; 1991 Jun 17; 39(6):1283-98. PubMed ID: 1895680
    [No Abstract] [Full Text] [Related]

  • 13. Erythrocyte transmembrane flux and renal clearance of oxalate in idiopathic calcium nephrolithiasis.
    Gambaro G, Petrarulo M, Nardelotto A, Marangella M, Baggio B.
    Kidney Int; 1995 Nov 17; 48(5):1549-52. PubMed ID: 8544412
    [Abstract] [Full Text] [Related]

  • 14. [Idiopathic calcium oxalate urinary lithiasis: new physiopathological approaches].
    Berland Y.
    Nephrologie; 1999 Nov 17; 20(7):363-9. PubMed ID: 10642984
    [Abstract] [Full Text] [Related]

  • 15. Nephrolithiasis: a consequence of renal epithelial cell exposure to oxalate and calcium oxalate crystals.
    Khan SR, Thamilselvan S.
    Mol Urol; 2000 Nov 17; 4(4):305-12. PubMed ID: 11156696
    [Abstract] [Full Text] [Related]

  • 16. [Determination of calcium, oxalate and inhibitory activity of the urine in patients with calcium nephrolithiasis].
    Han KH, Cao LC, Ying YL.
    Zhonghua Wai Ke Za Zhi; 1986 Mar 17; 24(3):173-5, 190. PubMed ID: 3757655
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Food oxalate: factors affecting measurement, biological variation, and bioavailability.
    Massey LK.
    J Am Diet Assoc; 2007 Jul 17; 107(7):1191-4; quiz 1195-6. PubMed ID: 17604750
    [Abstract] [Full Text] [Related]

  • 19. Genetic approach to the study of cellular ion transport anomalies in idiopathic calcium nephrolithiasis.
    Gambaro G, Marchini F, Budakovic A, Checchetto S, Baggio B.
    Contrib Nephrol; 1997 Jul 17; 122():189-92. PubMed ID: 9399064
    [No Abstract] [Full Text] [Related]

  • 20. Oxalate and calcium oxalate crystals are injurious to renal epithelial cells: results of in vivo and in vitro studies.
    Thamilselvan S, Khan SR.
    J Nephrol; 1998 Jul 17; 11 Suppl 1():66-9. PubMed ID: 9604816
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.